Related Experiment Video
Updated: Jul 24, 2025

Monitoring Changes in Human Umbilical Vein Endothelial Cells upon Viral Infection Using Impedance-Based Real-Time Cell Analysis
Published on: May 5, 2023
Endothelium dysfunction and thrombosis in COVID-19 with type 2 diabetes
Mengdi Li1,2, Xiaoming Wu2, Jialan Shi2,3,4
1Department of Endodontics, The First Hospital, Harbin Medical University, Harbin, China.
Type 2 diabetes patients with COVID-19 face higher thrombosis risks due to endothelial damage. Early antithrombotic therapy is crucial for better outcomes and managing long COVID complications.
Area of Science:
- Cardiovascular Medicine
- Infectious Diseases
- Endocrinology
Background:
- SARS-CoV-2 infection damages endothelial cells, increasing thrombosis risk, particularly in Type 2 Diabetes (T2D) patients.
- T2D patients exhibit increased susceptibility to severe COVID-19, thrombotic complications, and prolonged post-COVID-19 sequelae.
Purpose of the Study:
- To review mechanisms of endothelial dysfunction and thrombosis in T2D patients with COVID-19, including long COVID.
- To provide guidance on antithrombotic therapy and drug interactions for managing COVID-19 in T2D patients.
Main Methods:
- Literature review focusing on endothelial injury, phosphatidylserine exposure, hyperglycemia, hypoxia, and inflammation in COVID-19 and T2D.
- Analysis of thrombosis mechanisms, including PS-exposing particles, blood cells, and endothelial cells.
- Evaluation of antithrombotic strategies and drug interactions.
Main Results:
- Hyperglycemia, hypoxia, and inflammation contribute to endothelial dysfunction and hypercoagulability in T2D patients with COVID-19.
- Increased phosphatidylserine exposure on blood and endothelial cells promotes thrombosis.
- Early antithrombotic therapy, tailored to disease severity, is vital for improving prognosis.
Conclusions:
- Antithrombotic therapy is essential for T2D patients with COVID-19 to mitigate disease impact and reduce sequelae.
- Comprehensive management recommendations addressing drug interactions are needed to improve vaccine efficacy and patient quality of life.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Coronary Artery Disease II: Pathophysiology
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...

